Genetec Corporation (TYO:4492)
Japan flag Japan · Delayed Price · Currency is JPY
362.00
+2.00 (0.56%)
May 28, 2026, 3:30 PM JST

Genetec Income Statement

Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
10,9838,1247,1475,8644,683
Revenue Growth (YoY)
35.19%13.67%21.88%25.22%14.81%
Cost of Revenue
6,8354,8534,2393,5472,720
Gross Profit
4,1483,2712,9082,3171,963
Selling, General & Admin
3,3272,5772,2832,2111,772
Operating Expenses
3,3272,5772,2792,2111,772
Operating Income
821694629106191
Interest Expense
-30-11-7-3-
Interest & Investment Income
2----
Currency Exchange Gain (Loss)
-6-1-5-7-7
Other Non Operating Income (Expenses)
37-171469
EBT Excluding Unusual Items
824682634110253
Gain (Loss) on Sale of Assets
5----
Asset Writedown
--10-5-8-
Legal Settlements
----15-
Other Unusual Items
-3-11-1--137
Pretax Income
82666162887116
Income Tax Expense
3162402146460
Net Income
5104214142356
Net Income to Common
5104214142356
Net Income Growth
21.14%1.69%1700.00%-58.93%-67.63%
Shares Outstanding (Basic)
1211111111
Shares Outstanding (Diluted)
1212121111
Shares Change (YoY)
0.23%0.32%0.76%1.64%0.02%
EPS (Basic)
44.2236.8036.382.035.01
EPS (Diluted)
43.7836.2335.802.034.95
EPS Growth
20.84%1.20%1660.88%-58.93%-67.71%
Free Cash Flow
46385579-323-117
Free Cash Flow Per Share
3.9533.1349.97-28.09-10.34
Dividend Per Share
-18.00017.8333.3333.333
Dividend Growth
-0.94%435.01%--
Gross Margin
37.77%40.26%40.69%39.51%41.92%
Operating Margin
7.47%8.54%8.80%1.81%4.08%
Profit Margin
4.64%5.18%5.79%0.39%1.20%
Free Cash Flow Margin
0.42%4.74%8.10%-5.51%-2.50%
EBITDA
1,065849774259227
EBITDA Margin
9.70%10.45%10.83%4.42%4.85%
D&A For EBITDA
24415514515336
EBIT
821694629106191
EBIT Margin
7.47%8.54%8.80%1.81%4.08%
Effective Tax Rate
38.26%36.31%34.08%73.56%51.72%
Advertising Expenses
-335315442425
Source: S&P Global Market Intelligence. Standard template. Financial Sources.